Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Regan Stewart Sells 8,732 Shares of Stock

Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Regan Stewart sold 8,732 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of C$31.65, for a total value of C$276,373.04.

Jamieson Wellness Price Performance

Jamieson Wellness stock traded up C$0.04 during midday trading on Friday, reaching C$31.11. The company had a trading volume of 1,675 shares, compared to its average volume of 65,427. Jamieson Wellness Inc. has a 12-month low of C$22.10 and a 12-month high of C$33.14. The firm’s fifty day simple moving average is C$30.81 and its 200-day simple moving average is C$28.60. The company has a debt-to-equity ratio of 92.76, a current ratio of 3.21 and a quick ratio of 1.08. The company has a market capitalization of C$1.29 billion, a P/E ratio of 36.37 and a beta of 0.61.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on JWEL. TD Securities increased their price objective on shares of Jamieson Wellness from C$36.00 to C$40.00 in a research note on Friday, August 9th. Canaccord Genuity Group upped their price objective on shares of Jamieson Wellness from C$32.50 to C$36.25 in a research report on Friday, August 9th. BMO Capital Markets increased their target price on shares of Jamieson Wellness from C$35.00 to C$42.00 in a research note on Friday, August 9th. Royal Bank of Canada lifted their price target on Jamieson Wellness from C$32.00 to C$37.00 in a research note on Friday, August 9th. Finally, CIBC lowered their price target on Jamieson Wellness from C$28.00 to C$27.00 in a research report on Friday, May 10th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of C$36.36.

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.